Gunilla holds an MD, PhD and Associate Professor from Karolinska Institutet. Her wideranging experience covers all phases of drug development in small, medium and large companies. She is a co-founder of Gesynta Pharma and holds several board positions.
Holdings in the company: 88,420 shares and 190,897 employee warrants.
Independence: Gunilla is independent in relation to the company and is independent in relation to the Company’s largest shareholders.
Other Board assignments: Board member in Corline Biomedical AB, Haracon AB, Disruptive Pharma AB, Initiator Pharma A/S and Strike Pharma AB.